Trial of Oral Melatonin in Elevated Blood Pressure
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.
Also called NCT03764020
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 320 participants
- Registry
-
NCT03764020
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT03764020. Randomized; triple masking; primary purpose treatment. Start 2019-06-01 (anticipated); primary completion 2019-11-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial of Oral Melatonin in Elevated Blood Pressure
- Acronym
- MRCTEBP
- Condition
- Elevated Blood Pressure
- Intervention (Drug)
- Placebo oral capsule/placebo comparator
- Intervention (Drug)
- Melatonin/experimental
- Lead sponsor
- Tehran University of Medical Sciences
Record details
- Record id
cardio:ct-nct03764020- Content hash
753ae7cd8258a8b131b100af2fb5d24c53fd1ec8be769823862b620363a85265